Categorical vs dimensional classifications of psychotic disorders.

Melissa Potuzak, Caitlin Ravichandran, Kathryn E Lewandowski, Dost Ongür, Bruce M Cohen
Author Information
  1. Melissa Potuzak: Psychotic Disorders Division, McLean Hospital, 1125 Mill St., Belmont, MA 02478, USA.

Abstract

OBJECTIVE: Both categorical and dimensional methods appear relevant to classifying psychotic disorders; however, there is no clear consensus on the most appropriate categories and dimensions or on the best approach for constructing nosologic criteria that integrate these 2 methods. This review examines the evidence on specific dimensions and categories that would best characterize psychoses.
METHOD: Entries in the MEDLINE database between 1980 and 2011 were searched for studies of the dimensional and/or categorical structure of psychosis. Studies were included if samples represented a spectrum of psychotic disorders and dimensions/categories were empirically derived using principal components analysis, factor analysis, or latent class analysis.
RESULTS: Most dimensional studies observed 4 or 5 dimensions within psychosis, with positive, negative, disorganization, and affective symptom domains most frequently reported. Substance abuse, anxiety, early onset/developmental, insight, cognition, hostility, and behavioral/social disturbance dimensions appeared in some studies. Categorical studies suggested 3 to 7 major classes within psychosis, including a class similar to Kraepelin's dementia praecox and one or more classes with significant mood components. Only 2 studies compared the relative fit of empirically derived dimensions and categories within the same data set, and each had significant limitations.
CONCLUSION: There is relatively consistent evidence on appropriate categories and dimensions for characterizing psychoses. However, the lack of studies directly comparing or combining these approaches provides insufficient evidence for definitive conclusions about their relative merits and integration. The authors provide specific recommendations for designing future studies to identify valid dimensions and/or categories of the psychoses and investigate hybrid approaches to model the structure of the underlying illnesses.

References

  1. J Pers Assess. 2005 Aug;85(1):17-32 [PMID: 16083381]
  2. Am J Psychiatry. 1997 Feb;154(2):191-8 [PMID: 9016267]
  3. Eur Arch Psychiatry Clin Neurosci. 2002 Feb;252(1):12-8 [PMID: 12056576]
  4. Psychol Med. 2004 Oct;34(7):1177-86 [PMID: 15697044]
  5. Schizophr Res. 2003 May 1;61(1):47-57 [PMID: 12648735]
  6. Arch Gen Psychiatry. 1998 Jun;55(6):492-9 [PMID: 9633666]
  7. Schizophr Res. 1998 May 25;31(2-3):113-20 [PMID: 9689715]
  8. J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1085-1093 [PMID: 19797980]
  9. Br J Psychiatry. 1995 Feb;166(2):236-40 [PMID: 7728368]
  10. Acta Psychiatr Scand. 1998 May;97(5):334-42 [PMID: 9611083]
  11. Psychopathology. 2008;41(4):264-70 [PMID: 18441528]
  12. Schizophr Res. 2001 Mar 1;47(2-3):223-32 [PMID: 11278139]
  13. Br J Psychiatry. 2001 Jul;179:39-45 [PMID: 11435267]
  14. Schizophr Bull. 2012 May;38(3):495-505 [PMID: 20864620]
  15. Schizophr Res. 1998 May 4;31(1):57-70 [PMID: 9633837]
  16. Psychol Med. 2009 Dec;39(12):1943-55 [PMID: 19627645]
  17. Schizophr Res. 1994 Jun;12(3):213-21 [PMID: 8054313]
  18. Psychol Med. 2005 Apr;35(4):499-510 [PMID: 15856720]
  19. J Psychiatr Res. 2007 Nov;41(9):724-36 [PMID: 16762370]
  20. Soc Dev. 2010 Aug;19(3):470-493 [PMID: 24489441]
  21. Schizophr Res. 2002 Jul 1;56(1-2):129-36 [PMID: 12084427]
  22. Schizophr Res. 1992 Dec;8(2):143-56 [PMID: 1457393]
  23. Psychopharmacol Bull. 1975 Jul;11(3):22-5 [PMID: 1153649]
  24. Eur Arch Psychiatry Clin Neurosci. 2003 Apr;253(2):73-9 [PMID: 12799744]
  25. Psychiatry Res. 1994 Jun;52(3):295-303 [PMID: 7991723]
  26. Am J Psychiatry. 1997 Mar;154(3):371-7 [PMID: 9054785]
  27. J Nerv Ment Dis. 1998 Aug;186(8):470-6 [PMID: 9717864]
  28. Compr Psychiatry. 2001 Jan-Feb;42(1):32-8 [PMID: 11154713]
  29. Arch Gen Psychiatry. 1998 Jan;55(1):75-81 [PMID: 9435763]
  30. World Psychiatry. 2007 Jun;6(2):100-1 [PMID: 18235866]
  31. Acta Psychiatr Scand. 2003 May;107(5):378-84 [PMID: 12752034]
  32. Psychol Med. 2006 Dec;36(12):1671-80 [PMID: 16907995]
  33. Drug Alcohol Depend. 2011 Nov 1;118(2-3):166-72 [PMID: 21507586]
  34. Schizophr Bull. 1990;16(3):537-45 [PMID: 2287938]
  35. Schizophr Bull. 1974 Winter;(11):21-34 [PMID: 4619919]
  36. Eur Child Adolesc Psychiatry. 1999;8 Suppl 1:I29-35 [PMID: 10546981]
  37. Soc Psychiatry Psychiatr Epidemiol. 2007 Jun;42(6):429-37 [PMID: 17502977]
  38. Br J Psychiatry. 2006 Oct;189:346-53 [PMID: 17012658]
  39. Eur Arch Psychiatry Clin Neurosci. 2001 Aug;251(4):193-8 [PMID: 11697584]
  40. Schizophr Res. 2007 Jul;93(1-3):178-85 [PMID: 17383856]
  41. Am J Med Genet. 1996 Jul 26;67(4):393-400 [PMID: 8837708]
  42. Int J Methods Psychiatr Res. 2007;16 Suppl 1:S34-40 [PMID: 17623393]
  43. Psychiatry Res. 2004 Jun 30;127(1-2):101-9 [PMID: 15261709]
  44. Schizophr Res. 2001 Dec 1;52(3):215-29 [PMID: 11705715]
  45. Psychol Med. 1999 May;29(3):595-606 [PMID: 10405080]
  46. J Clin Psychiatry. 2010 Mar;71(3):327-37 [PMID: 20331934]
  47. Compr Psychiatry. 1994 Mar-Apr;35(2):135-44 [PMID: 8187478]
  48. Schizophr Res. 1999 Jul 27;38(1):13-26 [PMID: 10427607]
  49. Schizophr Bull. 2010 Jul;36(4):811-29 [PMID: 19176472]
  50. Biol Psychiatry. 1997 Nov 1;42(9):806-15 [PMID: 9347129]
  51. Psychol Med. 1996 Jan;26(1):161-76 [PMID: 8643756]
  52. Psychiatry Res. 2000 Dec 27;97(2-3):129-35 [PMID: 11166085]
  53. Psychol Assess. 2010 Sep;22(3):666-74 [PMID: 20822279]
  54. Compr Psychiatry. 1994 Jul-Aug;35(4):252-9 [PMID: 7956180]
  55. Alcohol Alcohol. 2011 May-Jun;46(3):333-41 [PMID: 21310744]
  56. Psychol Med. 1998 Jul;28(4):935-47 [PMID: 9723148]
  57. Schizophr Bull. 2003;29(3):413-25 [PMID: 14609237]
  58. Aust N Z J Psychiatry. 2000 Oct;34(5):792-800 [PMID: 11037365]
  59. Schizophr Bull. 2011 Mar;37(2):291-9 [PMID: 20861151]
  60. Schizophr Bull. 2004;30(4):855-73 [PMID: 15954195]
  61. J Am Acad Child Adolesc Psychiatry. 2002 Jul;41(7):791-8 [PMID: 12108803]
  62. Schizophr Bull. 1999;25(4):841-50 [PMID: 10667752]
  63. Schizophr Res. 2005 Nov 15;79(2-3):217-29 [PMID: 15993566]
  64. J Abnorm Psychol. 2010 Nov;119(4):631-9 [PMID: 20939653]
  65. Psychol Med. 2001 Jan;31(1):159-71 [PMID: 11200955]
  66. Addiction. 2006 Sep;101 Suppl 1:6-16 [PMID: 16930156]

Grants

  1. K23 MH091210/NIMH NIH HHS

MeSH Term

Comorbidity
Diagnostic and Statistical Manual of Mental Disorders
Humans
Psychiatric Status Rating Scales
Psychometrics
Psychotic Disorders
Reproducibility of Results
Schizophrenia
Schizophrenic Psychology

Word Cloud

Created with Highcharts 10.0.0dimensionsstudiescategoriesdimensionalpsychoticdisordersevidencepsychosespsychosisanalysiswithincategoricalmethodsappropriatebest2specificand/orstructureempiricallyderivedcomponentsclassCategoricalclassessignificantrelativeapproachesOBJECTIVE:appearrelevantclassifyinghoweverclearconsensusapproachconstructingnosologiccriteriaintegratereviewexaminescharacterizeMETHOD:EntriesMEDLINEdatabase19802011searchedStudiesincludedsamplesrepresentedspectrumdimensions/categoriesusingprincipalfactorlatentRESULTS:observed45positivenegativedisorganizationaffectivesymptomdomainsfrequentlyreportedSubstanceabuseanxietyearlyonset/developmentalinsightcognitionhostilitybehavioral/socialdisturbanceappearedsuggested37majorincludingsimilarKraepelin'sdementiapraecoxonemoodcomparedfitdatasetlimitationsCONCLUSION:relativelyconsistentcharacterizingHoweverlackdirectlycomparingcombiningprovidesinsufficientdefinitiveconclusionsmeritsintegrationauthorsproviderecommendationsdesigningfutureidentifyvalidinvestigatehybridmodelunderlyingillnessesvsclassifications

Similar Articles

Cited By